Skip to main content
Log in

Esophageal candidiasis in AIDS

Successful therapy with clotrimazole vaginal tablets taken by mouth

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

In this paper we describe the results of oral therapy of esophageal candidiasis with clotrimazole vaginal tablets in 25 homosexual men with AIDS, of whom 19 had oral candidiasis and 16 had esophageal symptoms. Therapy with clotrimazole vaginal tablets, 100 mg, taken by mouth cleared the esophageal symptoms, oral candidiasis, and esophageal lesions completely in all 25 men. Clotrimazole vaginal tablets are a useful alternative to other antifungal angents for the treatment of esophageal candidiasis in AIDS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Masur H, Fauci AS: Acquired immunodeficiency syndrome.In Gastrointestinal Disease, 4th ed. MH Sleisenger, JS Fordtran (ed). Philadelphia, WB Saunders, 1989, pp 1233–1242

    Google Scholar 

  2. Gottlieb MS, Groopman JE, Weinstein WM, Fahey JL, Detels R: The acquired immunodeficiency syndrome. Ann Intern Med 99:208–220, 1983

    Google Scholar 

  3. Ginsburg CH, Braden GL, Tauber AI, Trier JS: Oral clotrimazole in the treatment of esophageal candidiasis. Am J Med 71:891–895, 1981

    Google Scholar 

  4. Fazio RA, Wickremesinghe PC, Arsura EL: Ketoconazole treatment ofCandida esophagitis—a prospective study of 12 cases. Am J Gastroenterol 78:261–264, 1983

    Google Scholar 

  5. Tavitian A, Raufman J-P, Rosenthal LE, Weber J, Webber CA, Dincsoy HP: Ketoconazole-resistantCandida esophagitis in patients with acquired immunodeficiency syndrome. Gastroenterology 90:443–445, 1986

    Google Scholar 

  6. Smith PD: Gastrointestinal infections in patients with acquired immunodeficiency syndrome. Viewpoints Dig Dis 18:1–4, 1986

    Google Scholar 

  7. Young LS: Treatable aspects of infection due to human immunodeficiency virus. Lancet 2:1503–1506, 1987

    Google Scholar 

  8. Shepherd FA, Fanning MM, Duperval R, Dupuy JM, Garvey B, Joncas J, La Pointe N, Morisset R: A guide to the investigation and treatment of patients with AIDS and AIDS-related disorders. Can Med Assoc J 134:999–1008, 1986

    Google Scholar 

  9. Glatt AE, Chirgwin K, Landesman SH: Treatment of infections associated with human immunodeficiency virus. N Engl J Med 318:1439–1448, 1988

    Google Scholar 

  10. Centers for Disease Control: Update on acquired immune deficiency syndrome (AIDS)-United States. MMWR 31:507–514, 1982

    Google Scholar 

  11. Deschamps M-MH, Pape JW, Verdier RI, DeHovitz J, Thomas F, Johnson WD Jr: Treatment ofCandida esophagitis in AIDS patients. Am J Gastroenterol 83:20–21, 1988

    Google Scholar 

  12. Fluconazole. Med Lett 32:50–52, 1990

  13. Duarte PA, Chow CC, Simmons F, Ruskin J: Fatal hepatitis associated with ketoconazole therapy. Arch Intern Med 144:1069–1070, 1984

    Google Scholar 

  14. Bercoff E, Bernuau J, Degott C, Kalis B, Lemaire A, Tilly H, Rueff B, Benhamou JP: Ketoconazole-induced fulminant hepatitis. Gut 26:636–638, 1985

    Google Scholar 

  15. Engelhard D, Stutman HR, Marks MI: Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med 311:1681–1683, 1984

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lalor, E., Rabeneck, L. Esophageal candidiasis in AIDS. Digest Dis Sci 36, 279–281 (1991). https://doi.org/10.1007/BF01318196

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01318196

Key words

Navigation